Condition: Lymphoedema of Leg · Lymphedema Arm · Lymphedema · Sponsor: Universitaire Ziekenhuizen KU Leuven
The primary objective of this research proposal is to investigate * in patients with lymphoedema of the upper limb or lower limb (P) * the added value of reconstructive lymphatic surgery (I) * to the decongestive lymphatic therapy (usual care) (C) * on the lymphoedema-specific quality of life (QoL) (O) * at 18 months post-surgery/ no surgery (T) Consequently, a multicentre pragmatic randomised controlled trial is performed to give an answer on following research question: 'Is, in addition to usual care - i.e. decongestive lymphatic therapy -, reconstructive lymphatic surgery (intervention group) superior to no surgery (control group), for the treatment of upper or lower limb lymphoedema?'
This description comes directly from the study's public registry record.
Nele Devoogdt · 0032 16 34 25 15 · nele.devoogdt@kuleuven.be
Tessa De Vrieze · 0032 16 34 50 06 · tessa.devrieze@kuleuven.be
Always discuss trial participation with your own doctor first.
| Ghent University Hospital | Ghent, Belgium | Recruiting |
| University Hospitals of Leuven, center for lymphedema | Leuven, Belgium | Recruiting |
| CHU-UCL Mont-Godinne | Namur, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05064176